Assessing Interest in Web/App Platforms for Early Phase Clinical Trial Recruitment

Not yet recruiting

• Conditions: Assessing Interest in a Platform for Early Phase Clinical Trial Recruitment
• Interventions: Other: Questionnaires

• Registration Number: NCT06302647
• Lead Sponsor: Instituto de Investigación Hospital Universitario La Paz

Brief Summary

Study objective:

To assess whether the different stakeholders (volunteers, patients, doctors and industry) involved in early phase trials would be interested in using a platform to facilitate recruitment and engagement in this type of trials. In addition, we will also evaluate the degree of awareness existing in society about clinical trials.

Study subjects: General population, patient, physicians, pharmaceutical-biotechnological industry.

Keywords: healthy volunteer, patient, pharma industry, patient associaiton, questionnaire, clinical trial, platform, recruitment, engagement.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-03
• Study First Submitted: 2024-03-04
• Study First Submitted QC: 2024-03-04
• Study First Posted: 2024-03-12
• Last Update Submitted: 2024-03-12
• Study Start: 2024-03-14
• Last Update Posted: 2024-03-15
• Primary Completion: 2024-06-15
• Study Completion: 2024-06-30

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Participant will be over 18 years old.
• Male, female or do not want to specify.
• Participants will be capable to understand spanish language.
• Subjects able to communicate with the investigator and able to read and write and follow all study instructions.

Exclusion Criteria

• Individuals not willing to complete the eraly phase clinical trial platform Study survey
• Individuals who do not meet eligibility criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Questionnaire for pharma/biotech industry	Questionnaires	Questionnaire will be provided to Pharma/biotech industry anonymously to gain knowledge on their willigness to use a platform to promote the recruitment in early phase clinical trials.
Questionnaire for subjects	Questionnaires	Questionnaire will be provided to general subjects anonymously to gain knowledge on their willigness to use a platform to look for early phase clinical trials.
Questionnaire for doctors	Questionnaires	Questionnaire will be provided to Pharma/biotech industry anonymously to gain knowledge on their willigness to use a platform to have information and promote the recruitment in early phase clinical trials.

Primary Outcome Measures

Name	Time	Method
percentage of each of the three groups that would find the platform useful	3 months	It would be deemed useful if they respond affirmatively or, in the case of a numerical scale from 1 to 5 being 1 the worse o low results and 5 the best or highest, if rate it above 4 in 80% of the questions regarding the utility of the platform.